If you're looking the next up-and-coming stocks then look no further than Cabot Small-Cap Confidential. We limit the circulation of our advisory so that our subscribers own the stocks before the big institutions start buying them.
Each month Chief Analyst Thomas Garrity will present a new small-cap stock with his in-depth research. You'll see many stocks from emerging technologies, including mobile telecommunications, biotech, cyber security, genetic medicine, bio-pharmaceuticals, sensors, robotics and other fields with unlimited upside potential.
Cabot Small-Cap Confidential's focus is on finding undervalued and little-known small-cap companies with big ideas that serve very large markets. The advisory recommends one stock each month, and usually holds them as long-term investments. The advisory does not present a model portfolio—i.e., there's no cash position, weightings, etc.; however, all recommendations are followed up weekly with buy, hold and eventually sell ratings.The performance shown is the average gain of Cabot Small-Cap Confidential stocks since inception on 10/8/07, excluding current holdings as of 6/29/15.
235% in Baxano Surgical
187% in Ovascience
148% in Cardiovascular Systems
116% in Cerus
Navgiate the fast-paced world of small-cap stocks with Cabot Small-Cap Confidential. This limited-circulation advisory will help you find the technologies of tomorrow, with virtually limitless profit opportunities.
Sign up now for a risk-free trial subscription to Cabot Small-Cap Confidential. If you don’t like it, you'll receive a pro-rated refund.
What our Customers say about Small-Cap Confidential
The newsletter lets you build a portfolio that is more fun to watch, with potentially greater rewards.
K. Rutz, Columbus, Ohio
Tom, I just read your Game Changers report. I've been waiting for a new start-up company dealing with 3-D printing. The future is bright. I'm 73, so my investment time is limited, but I introduced my son to your advisory—he's a finance major so I know his investment future is promising. Keep up the good work.
B. Gonzalez, Palos Heights, Illinois
A well researched, easy to read and honestly "marketed" newsletter that has pumped up my portfolio. I have been a Cabot subscriber for several years, a Small-Cap subscriber for a few months, and spent the "big bucks" because of my confidence in the integrity of the Cabot organization. My trust is not easily bestowed...Cabot has worked hard to earn that trust.
F. Odon, Olmsted Falls, Ohio
Are you ready to get started with your risk-free trial subscription?